CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SRPT

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

1

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Oct '26
SRPTPhase 3

Eteplirsen Phase 3 Est. Readout

Eteplirsen
Oct 2026~
CT.gov
00%
Drug Information

Target Indication

Duchenne Muscular Dystrophy

Clinical Trial

NCT03218995

Last updated: 12/29/2025

Patent & Exclusivity
ActiveRLD

Latest Patent Expiry

Mar 14, 2034(7y 6m)

Patents Listed

5

Application

NDA 206488
Regulatory Approvals
EMAPending

Exondys

Treatment of Duchenne muscular dystrophy.

Orphan
View on EMA
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.